256 related articles for article (PubMed ID: 35269926)
21. Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice.
Rajlic S; Surmann L; Zimmermann P; Weisheit CK; Bindila L; Treede H; Velten M; Daiber A; Duerr GD
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293543
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of fatty acid amides in the carrageenan-induced paw edema model.
Wise LE; Cannavacciulo R; Cravatt BF; Martin BF; Lichtman AH
Neuropharmacology; 2008 Jan; 54(1):181-8. PubMed ID: 17675189
[TBL] [Abstract][Full Text] [Related]
23. Fatty acid amide hydrolase determines anandamide-induced cell death in the liver.
Siegmund SV; Seki E; Osawa Y; Uchinami H; Cravatt BF; Schwabe RF
J Biol Chem; 2006 Apr; 281(15):10431-8. PubMed ID: 16418162
[TBL] [Abstract][Full Text] [Related]
24. Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase.
Liu J; Cinar R; Xiong K; Godlewski G; Jourdan T; Lin Y; Ntambi JM; Kunos G
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18832-7. PubMed ID: 24191036
[TBL] [Abstract][Full Text] [Related]
25. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase.
Kaczocha M; Hermann A; Glaser ST; Bojesen IN; Deutsch DG
J Biol Chem; 2006 Apr; 281(14):9066-75. PubMed ID: 16461355
[TBL] [Abstract][Full Text] [Related]
26. Computational insights into function and inhibition of fatty acid amide hydrolase.
Palermo G; Rothlisberger U; Cavalli A; De Vivo M
Eur J Med Chem; 2015 Feb; 91():15-26. PubMed ID: 25240419
[TBL] [Abstract][Full Text] [Related]
27. Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition.
Morgillo CM; Lupia A; Deplano A; Pirone L; Fiorillo B; Pedone E; Luque FJ; Onnis V; Moraca F; Catalanotti B
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555144
[TBL] [Abstract][Full Text] [Related]
28. Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction.
Wenzel D; Matthey M; Bindila L; Lerner R; Lutz B; Zimmer A; Fleischmann BK
Proc Natl Acad Sci U S A; 2013 Nov; 110(46):18710-5. PubMed ID: 24167249
[TBL] [Abstract][Full Text] [Related]
29. Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).
Lodola A; Castelli R; Mor M; Rivara S
Expert Opin Ther Pat; 2015; 25(11):1247-66. PubMed ID: 26413912
[TBL] [Abstract][Full Text] [Related]
30. Fluorimetric Assay of FAAH Activity.
Angelucci CB; Giacominelli-Stuffler R; Maccarrone M
Methods Mol Biol; 2023; 2576():249-260. PubMed ID: 36152193
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice.
Mayo LM; Asratian A; Lindé J; Holm L; Nätt D; Augier G; Stensson N; Vecchiarelli HA; Balsevich G; Aukema RJ; Ghafouri B; Spagnolo PA; Lee FS; Hill MN; Heilig M
Mol Psychiatry; 2020 May; 25(5):993-1005. PubMed ID: 30120421
[TBL] [Abstract][Full Text] [Related]
32. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
[TBL] [Abstract][Full Text] [Related]
33. A second fatty acid amide hydrolase with variable distribution among placental mammals.
Wei BQ; Mikkelsen TS; McKinney MK; Lander ES; Cravatt BF
J Biol Chem; 2006 Dec; 281(48):36569-78. PubMed ID: 17015445
[TBL] [Abstract][Full Text] [Related]
34. Amygdala FAAH and anandamide: mediating protection and recovery from stress.
Gunduz-Cinar O; Hill MN; McEwen BS; Holmes A
Trends Pharmacol Sci; 2013 Nov; 34(11):637-44. PubMed ID: 24325918
[TBL] [Abstract][Full Text] [Related]
35. Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.
Charrua A; Matos R; Oliveira R; Marczylo T; Nagy I; Cruz F
Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):263-272. PubMed ID: 31522241
[TBL] [Abstract][Full Text] [Related]
36. Antidepressant-like effects of pharmacological inhibition of FAAH activity in socially isolated female rats.
Carnevali L; Statello R; Vacondio F; Ferlenghi F; Spadoni G; Rivara S; Mor M; Sgoifo A
Eur Neuropsychopharmacol; 2020 Mar; 32():77-87. PubMed ID: 31948828
[TBL] [Abstract][Full Text] [Related]
37. Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro.
Dongdem JT; Helegbe GK; Opare-Asamoah K; Wezena CA; Ocloo A
BMC Pharmacol Toxicol; 2022 Jan; 23(1):1. PubMed ID: 34983657
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
39. FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.
Ravi J; Sneh A; Shilo K; Nasser MW; Ganju RK
Oncotarget; 2014 May; 5(9):2475-86. PubMed ID: 24811863
[TBL] [Abstract][Full Text] [Related]
40. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
